Key Takeaway
This review from the Conboy lab at UC Berkeley provides the theoretical framework for using therapeutic plasma exchange as a rejuvenation therapy, arguing that diluting age-elevated circulating factors can recalibrate signaling pathways to a youthful state.
Summary
This perspective and review article from the Conboy laboratory at UC Berkeley synthesizes evidence that aging is perpetuated by circulating systemic factors that accumulate with age and impair stem cell activation, leading to tissue decline. The authors summarize how old, damaged tissues secrete factors into circulation that serve as both biomarkers for age-associated pathologies and active inducers of degenerative phenotypes.
The review discusses recent advances using plasmapheresis in both preclinical (mouse heterochronic parabiosis and blood exchange) and clinical settings. The central thesis is that therapeutic plasma exchange can be "repositioned" from its traditional clinical uses to serve as a rejuvenation therapy by diluting the systemic factors that become deleterious at age-elevated levels.
The authors postulate that this approach could be a rapidly effective intervention that recalibrates crucial signaling pathways, including those governing inflammation, fibrosis, and stem cell function, to a more youthful state. This paper laid important groundwork for the subsequent clinical studies by the same group.
Methods
- Narrative review and perspective article
- Summarized preclinical parabiosis and blood exchange studies in mice
- Reviewed clinical plasmapheresis literature
- Discussed systemic determinants of age-related tissue dysfunction
Key Results
- Age-elevated circulating factors impair stem cell activation and tissue homeostasis
- Old tissues secrete factors that serve as both biomarkers and active drivers of aging
- Preclinical evidence supports blood factor dilution as a rejuvenation mechanism
- Therapeutic plasma exchange can dilute deleterious age-elevated systemic factors
- Proposed mechanism: recalibration of signaling pathways to youthful state
Limitations
- Review/perspective article, not primary research
- No new experimental data presented
- Theoretical framework not yet validated by large clinical trials at time of publication
- Does not address optimal TPE protocols, frequency, or duration
- Potential bias as authors are proponents of the plasma dilution hypothesis